Note: This story has been updated Aug. 11, 2023, to correct the definition of a rare disease, which is defined…
Articles by Lindsey Shapiro, PhD
A year of treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) led to gains in lung function and nutritional status for cystic…
Hispanic cystic fibrosis (CF) patients are at a higher risk of developing Staphylococcus aureus lung infections — and…
A protein from scorpionfish might combat antibiotic-resistant bacterial infections in cystic fibrosis (CF) patients, a recent study suggests. The…
Being treated with Kaftrio or Symveki led to a reduced need for insulin in people with cystic…
The European Commission approved expanding the use of Orkambi (lumacaftor/ivacaftor) to include children as young as 1 year old…
The personality traits of people with cystic fibrosis (CF) might influence their health-related quality of life (HRQoL), according to…
Men with cystic fibrosis (CF) saw greater reductions in lung symptom exacerbations after starting treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor)…
A young man with cystic fibrosis (CF) has become the first patient in the U.S. to undergo MRI lung…
Reducing the use of supportive therapies after starting Trikafta (elexacaftor/tezacaftor/ivacaftor) didn’t negatively impact health outcomes among cystic fibrosis…